Meeder Asset Management Inc Intellia Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 233 shares of NTLA stock, worth $2,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares

233

Previous 149 56.38%

Holding current value

$2,814

Previous $3,000 33.33%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$19.72 - $27.36 $1,656 - $2,298	84 Added 56.38%	233 $4,000
Q2 2024 Aug 08, 2024	BUY	$20.02 - $27.22 $520 - $707	26 Added 21.14%	149 $3,000
Q1 2024 May 07, 2024	BUY	$23.82 - $32.8 $2,929 - $4,034	123 New	123 $3,000
Q4 2021 Feb 11, 2022	SELL	$100.76 - $138.36 $194,567 - $267,173	-1,931 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$132.37 - $176.78 $19,987 - $26,693	-151 Reduced 7.25%	1,931 $258,000
Q2 2021 Aug 09, 2021	BUY	$60.88 - $161.91 $19,359 - $51,487	318 Added 18.03%	2,082 $337,000
Q1 2021 Apr 28, 2021	BUY	$46.59 - $83.68 $82,184 - $147,611	1,764 New	1,764 $142,000
Q4 2020 Feb 09, 2021	SELL	$18.83 - $63.53 $66,225 - $223,435	-3,517 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$17.47 - $24.93 $5,992 - $8,550	-343 Reduced 8.89%	3,517 $69,000
Q2 2020 Aug 11, 2020	BUY	$11.14 - $22.87 $41,808 - $85,831	3,753 Added 3507.48%	3,860 $80,000
Q1 2020 May 15, 2020	BUY	$9.44 - $15.58 $1,010 - $1,667	107 New	107 $1,000
Q3 2019 Oct 17, 2019	SELL	$13.07 - $18.51 $1,555 - $2,202	-119 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$13.88 - $18.41 $1,651 - $2,190	119 New	119 $2,000
Q4 2018 Jan 17, 2019	SELL	$11.39 - $27.13 $125 - $298	-11 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$25.78 - $32.6 $283 - $358	11 New	11 $0
Q2 2018 Jul 24, 2018	SELL	$20.02 - $30.79 $1,541 - $2,370	-77 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$19.43 - $34.95 $4,235 - $7,619	-218 Reduced 73.9%	77 $2,000
Q4 2017 Feb 02, 2018	BUY	$17.39 - $31.12 $2,191 - $3,921	126 Added 74.56%	295 $6,000
Q3 2017 Oct 20, 2017	BUY	$15.16 - $25.75 $2,562 - $4,351	169	169 $4,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $918M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Intellia Therapeutics, Inc. Transaction History